Liver Cancer Risk Factor
Hepatitis B immunization reduces incidence of hepatocellular carcinoma
Published in Vaccine Weekly, December 24th, 2003
According to published research from Taiwan, "Hepatocellular carcinoma (HCC) is one of the 10 most common malignant tumors worldwide. Chronic infection with hepatitis B or C virus is closely related to hepatocarcinogenesis. The outcome of current therapies for HCC is not satisfactory."
"Prevention is the best way to control HCC," said Mei-Hwei Chang at National Taiwan University Hospital. "Among the various strategies of HCC prevention, immunization against hepatitis B virus infection is the most effective. Universal hepatitis B...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2003-12-24)
More Articles from Vaccine Weekly
- Toxoplasmosis Vaccine
Toxoplasma protein and DNA vaccine loaded chitosan particles prepared - Vaccine Development
Functionalized carbon nanotubes enhance specific antibody responses - Antitumor Radiotherapy
Leaky radiohalogen labels used in targeting tumors can be modified for retention - HIV/AIDS Vaccine
GX-12 HIV therapeutic vaccine appears safe - T Cell Function
Strength and persistence of antigen stimulation will alter T cell responses - Toxoplasmosis Vaccine
Vaccine protects against toxoplasmosis in BALB/c but not CBA/J mice - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
